<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1207268</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2023.1207268</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: <italic>Phyllanthus</italic> niruri L. exerts protective effects against the calcium oxalate-induced renal injury via ellgic acid</article-title>
<alt-title alt-title-type="left-running-head">Li et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1207268">10.3389/fphar.2023.1207268</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Mao-Ting</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1775038/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Lu-Lu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1825450/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Qi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1825474/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Lin-Xi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1825676/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Yu-Xuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1825451/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hou</surname>
<given-names>Jie-Bin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1373795/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Hong-Tao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1826435/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Bing</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1284129/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/570863/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guo</surname>
<given-names>Zhi-Yong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/513594/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Changhai Hospital</institution>, <institution>Naval Medical University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Nephrology</institution>, <institution>the Second Medical Centre</institution>, <institution>Chinese PLA General Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Naval Medicine</institution>, <institution>Naval Medical University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Cell Biology</institution>, <institution>Center for Stem Cell and Medicine</institution>, <institution>Navy Medical University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/257180/overview">Ying-Yong Zhao</ext-link>, Northwest University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Wei Chen, <email>wujiang02@163.com</email>; Zhi-Yong Guo, <email>drguozhiyong@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1207268</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>06</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Li, Liu, Zhou, Huang, Shi, Hou, Lu, Yu, Chen and Guo.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Li, Liu, Zhou, Huang, Shi, Hou, Lu, Yu, Chen and Guo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Pharmacol." journal-id-type="nlm-ta" xlink:href="10.3389/fphar.2022.891788" ext-link-type="doi">A Corrigendum on <article-title>
<italic>Phyllanthus</italic> niruri L. exerts protective effects against the calcium oxalate-induced renal injury via ellgic acid</article-title> by Li M-T, Liu L-L, Zhou Q, Huang L-X, Shi Y-X, Hou J-B, Lu H-T, Yu B, Chen W and Guo Z-Y (2022). Front. Pharmacol. 13:891788. doi: <object-id>10.3389/fphar.2022.891788</object-id>
</related-article>
<kwd-group>
<kwd>
<italic>Phyllanthus</italic> niruri L.</kwd>
<kwd>calcium oxalate-induced renal injury</kwd>
<kwd>network pharmacology</kwd>
<kwd>ellagic acid</kwd>
<kwd>lipid nephrotoxicity</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Renal Pharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there were errors in <xref ref-type="fig" rid="F4">Figure 4A</xref> and <xref ref-type="fig" rid="F5">Figure 5D</xref> as published In <xref ref-type="fig" rid="F4">Figure 4A</xref>, the concentration unit of EA in the column chart is marked as &#x201c;mM&#x201d;, while the correct concentration unit in the text is &#x201c;&#x3bc;M&#x201d;. In <xref ref-type="fig" rid="F5">Figure 5D</xref> (Con/SQLE) panels, due an error had been made in the labelling of the original images, the immunohistochemical images of the Con/SQLE groups were incorrectly selected. We revised the semi-quantitative histograms of the positive expression area of HMGCS1, SCD and SQLE in <xref ref-type="fig" rid="F5">Figure 5D</xref> in order to present the results more clearly. The corrected <xref ref-type="fig" rid="F4">Figure 4</xref> and <xref ref-type="fig" rid="F5">Figure 5</xref> and their caption appear below.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Ellagic acid protects NaOx-induced injury in cells and reduces the expression of SQLE, HMGCS1, and SCD <bold>(A)</bold> The cytotoxicity of ellagic acid on HK-2 cells determined by the CCK8 assay <bold>(B)</bold> The cytotoxicity of ellagic acid on NaOx treated HK-2 cells determined by the CCK8 assay <bold>(C)</bold> The expression of SQLE, HMGCS1, and SCD by Western blot in the control group (Ctrl), sodium oxalate group (NaOx), and ellagic acid treatment group (NaOx &#x2b; EA) <bold>(D)</bold> Cells were analyzed by immunocytochemistry (100X) in the control group (Ctrl), sodium oxalate group (NaOx), and ellagic acid treatment group (NaOx &#x2b; EA).</p>
</caption>
<graphic xlink:href="fphar-14-1207268-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Ellagic acid protects calcium oxalate-induced renal injury in mice and reduces the expression of SQLE, HMGCS1, and SCD <bold>(A)</bold> Representative light microscopy images of hematoxylin and eosin staining of kidneys from the control group (Con), glyoxylate-induced CaOx group (Gly), and ellagic acid treatment group (Gly &#x2b; EA) (magnification, &#xd7;200; scale bar &#x3d; 50&#xa0;&#x3bc;m) <bold>(B)</bold> Serum creatinine level in control group (Con), glyoxylate-induced CaOx group (Gly), and ellagic acid treatment group (Gly &#x2b; EA) <bold>(C)</bold> The GPx activities, MDA, and total calcium content in control group (Con), glyoxylate-induced CaOx group (Gly), and ellagic acid treatment group (Gly &#x2b; EA) <bold>(D)</bold> Expression of SCD, HMGCS1, and SQLE were analyzed by immunohistochemistry (IHC) (left) Representative light microscopy images of IHC staining of kidney of mice (magnification, &#xd7;200; scale bar &#x3d; 50&#xa0;&#x3bc;m (up) and 25&#xa0;&#x3bc;m (down)) (right) Semi-quantitative score of SCD, HMGCS1, and SQLE.</p>
</caption>
<graphic xlink:href="fphar-14-1207268-g005.tif"/>
</fig>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec sec-type="disclaimer" id="s1">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>